CNBC 快讯 4月13日 12:04 Revolution Medicines胰腺癌突破性药物3期试验成功：可交易的Biotech催化剂分析 Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial. FG 100 读报告 →